In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance

Tegobuvir (GS-9190) is a non-nucleoside inhibitor of HCV RNA replication with proven antiviral activity in HCV-infected patients. The in vitro antiviral activity of Tegobuvir, when combined with one or two other direct acting antivirals (DAA) was assessed. When Tegobuvir was combined with either int...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Antiviral Research 2015-08, Vol.120 (1), p.112-121
Hauptverfasser:	Vliegen, Inge, Paeshuyse, Jan, Zhong, Weidong, Neyts, Johan
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!